- Home
- FNLC vs ZURA Comparison
FNLC vs ZURA Comparison
Compare FNLC & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- ZURA
- Stock Information
- Founded
- FNLC 1864
- ZURA 2022
- Country
- FNLC United States
- ZURA United States
- Employees
- FNLC N/A
- ZURA N/A
- Industry
- FNLC Major Banks
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNLC Finance
- ZURA Health Care
- Exchange
- FNLC Nasdaq
- ZURA Nasdaq
- Market Cap
- FNLC 295.4M
- ZURA 292.1M
- IPO Year
- FNLC 1999
- ZURA N/A
- Fundamental
- Price
- FNLC $26.77
- ZURA $2.21
- Analyst Decision
- FNLC
- ZURA Buy
- Analyst Count
- FNLC 0
- ZURA 6
- Target Price
- FNLC N/A
- ZURA $15.80
- AVG Volume (30 Days)
- FNLC 17.6K
- ZURA 563.1K
- Earning Date
- FNLC 01-22-2025
- ZURA 11-07-2024
- Dividend Yield
- FNLC 5.20%
- ZURA N/A
- EPS Growth
- FNLC N/A
- ZURA N/A
- EPS
- FNLC 2.38
- ZURA N/A
- Revenue
- FNLC $78,192,000.00
- ZURA N/A
- Revenue This Year
- FNLC N/A
- ZURA N/A
- Revenue Next Year
- FNLC N/A
- ZURA N/A
- P/E Ratio
- FNLC $11.64
- ZURA N/A
- Revenue Growth
- FNLC N/A
- ZURA N/A
- 52 Week Low
- FNLC $21.77
- ZURA $2.00
- 52 Week High
- FNLC $31.05
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- FNLC 31.37
- ZURA 33.78
- Support Level
- FNLC $26.12
- ZURA $2.16
- Resistance Level
- FNLC $28.16
- ZURA $2.66
- Average True Range (ATR)
- FNLC 0.65
- ZURA 0.24
- MACD
- FNLC -0.35
- ZURA 0.01
- Stochastic Oscillator
- FNLC 0.00
- ZURA 12.35
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.